BCL2 and hepatocellular carcinoma: Our data demonstrate that embelin is able to change the mitochondrial membrane potential to promote the shift of Bax and Bcl-2 as well as the release of cytochrome c, which results in the apoptosis of HepG2 human hepatocellular carcinoma cells.